TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
SARomics Biostructures AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,587
|
2,389
|
2,239 |
Financial expenses |
2
|
51
|
8 |
Earnings before taxes |
85
|
244
|
166 |
EBITDA |
107
|
305
|
239 |
Total assets |
1,410
|
1,404
|
1,375 |
Current assets |
979
|
1,030
|
935 |
Current liabilities |
570
|
625
|
723 |
Equity capital |
793
|
726
|
592 |
- share capital |
12
![]() |
12
|
13 |
Employees (average) |
27
|
22
|
20 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
56.2%
|
51.7%
|
43.1% |
Turnover per employee |
96
|
109
|
112 |
Profit as a percentage of turnover |
3.3%
|
10.2%
|
7.4% |
Return on assets (ROA) |
6.2%
|
21.0%
|
12.7% |
Current ratio |
171.8%
|
164.8%
|
129.3% |
Return on equity (ROE) |
10.7%
|
33.6%
|
28.0% |
Change turnover |
191
|
332
|
372 |
Change turnover % |
8%
|
16%
|
20% |
Chg. No. of employees |
5
|
2
![]() |
2 |
Chg. No. of employees % |
23%
|
10%
|
11% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.